[Form 4] BrightView Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

BrightView Holdings, Inc. (BV) director Francisco Lopez Jr. reported the acquisition of 1,930 shares of BrightView common stock on 09/30/2025 at a reported price of $13.40 per share. Following the transaction, Mr. Lopez beneficially owned 81,258 shares. The filing states these shares represent vested common stock issued as director compensation in lieu of cash. The Form 4 was signed by an attorney-in-fact on 10/01/2025. No other transactions or derivative holdings are reported in this filing.

Positive

• Director received vested common stock as compensation, which can align the reporting person's interests with shareholders
• Clear disclosure of transaction details including date, price, and resulting beneficial ownership (1,930 shares at $13.40; 81,258 shares owned)

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine equity award to a director, paid in shares rather than cash, aligns director and shareholder interests without indicating material change.

The Form 4 discloses a standard director compensation event: 1,930 vested shares issued in lieu of cash. Such grants are commonly used to conserve cash while providing pay linked to company performance. The report shows the director's total beneficial ownership of 81,258 shares after the award, which is valuable for transparency on insider holdings. The filing contains no indications of atypical timing, derivative transactions, or related-party complexities.

Securities Analyst

TL;DR: Non-derivative issuance of vested shares to a director; transactional details are straightforward and immaterial on their face.

The transaction is a direct acquisition (code A) of common stock recorded at $13.40 per share, consistent with stock-based director compensation. The Form 4 provides clear quantities and resulting ownership, aiding monitoring of insider alignment. There are no reported sales, exercises, or derivative positions tied to this filing, limiting immediate market impact based on the disclosed information alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lopez Francisco Jr.

(Last) (First) (Middle)

C/O BRIGHTVIEW HOLDINGS, INC.

980 JOLLY ROAD, SUITE 300

(Street)

BLUE BELL PA 19422

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightView Holdings, Inc. [ BV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		A(1)		1,930	A	$13.4	81,258	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vested shares of Issuer common stock issued as director compensation in lieu of cash.

	/s/ Jonathan M. Gottsegen, as Attorney-in-Fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BrightView (BV) director Francisco Lopez Jr. report on Form 4?

Mr. Lopez reported the acquisition of 1,930 common shares on 09/30/2025, recorded at $13.40 per share.

Why were the 1,930 shares issued to the director?

The filing states the shares represent vested common stock issued as director compensation in lieu of cash.

How many BrightView shares does Francisco Lopez Jr. beneficially own after the transaction?

Following the reported transaction, Mr. Lopez beneficially owned 81,258 shares.

When was the Form 4 signed and by whom?

The Form 4 was signed by an attorney-in-fact (Jonathan M. Gottsegen) on 10/01/2025.

Does the filing report any derivative securities or sales by the director?

No. The filing reports only a non-derivative acquisition of common stock and no derivative securities or dispositions.